Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1b study of HJB647 in Japanese adults with elevated blood pressure or hypertension
jRCT2071260050Phase 1Recruiting
- Sponsor
- Novartis
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of HJB647 in hypertension (HTN) (4 arms), sponsored by Novartis. Primary endpoints: Maximum plasma concentration, Time to maximum plasma concentration and 4 more. Started Jul 2026; status: recruiting.
02
Drugs
HJB647
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on jRCT2071260050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071260050.